Zhongnan Medical Journal Press

Home Results

A total of 310 result was found. Results that relate to Drug

Research progress on the synergistic effects of active components from traditional Chinese medicine in reversing tumor multidrug resistance

Published on Frontiers in Pharmaceutical Sciences 2025,29(10):1787-1793.
2760 times 423 times

CHENG Bing SONG Min XU Lingxia

Tumor multidrug resistance Active components of traditional Chinese medicine Synergistic effect Molecular mechanism
Details
Research on the safety of anesthetic drugs and intervention strategies in neonates and infants

Published on Frontiers in Pharmaceutical Sciences 2025,29(10):1794-1800.
2387 times 391 times

KE Yanjun CHEN Jiefeng PAN Zhengbin ZHENG Yangjiong ZHU Qi

Neonatal anesthesia Developmental neurotoxicity Drug safety Neuroprotection Intervention strategies
Details
Challenges and new advances in antitubercular drug therapy for renal transplant recipients

Published on Frontiers in Pharmaceutical Sciences 2025,29(11):1975-1980.
2726 times 412 times

ZHANG Wei ZHANG Yaxin LIU Yuanyuan YAN yan SUN Kun JI Zhaoshuai

Renal transplantation Tuberculosis Drug-drug interactions Pharmacotherapy Drug-resistant tuberculosis Recent progress in therapy
Details
Identification of potential drug targets for restless legs syndrome by Mendelian randomization analysis based on plasma proteomics

Published on New Medicine 2025,35(10):1181-1187.
2564 times 446 times

ZHANG Qinli XU Hua HAN Xiuyan LIU Hong

Restless legs syndrome Mendelian randomization Drug targets Plasma proteomics
Details
Research progress of LRPPRC in non-small cell lung cancer

Published on New Medicine 2025,35(10):1228-1234.
2843 times 481 times

LE Sihong ZHANG Qin FANG Weidan KUANG Peng ZHANG Ling

Non-small cell lung cancer LRPPRC Drug resistance Regulation mechanisms Immunotherapy
Details
Insights on facilitators and barriers to regulating non-medical use of prescription opioids: a qualitative study

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1265-1275.
2208 times 382 times

DUAN Yuehan ZHOU Huziwei YANG Yingzi WEN Qiaorui CHU Hongling WANG Jingling JIANG Zhiqin SUN Yexiang ZHU Yu WANG Shengfeng

Opioid Non-medical use Drug abuse Substance addiction Drug regulation Qualitative study
Details
Research advances in adverse drug reactions and their management in targeted therapy for driver gene-positive advanced non-small cell lung cancer

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1320-1329.
1977 times 358 times

FAN Jiameng PAN Lei

Non-small cell lung cancer Target therapy Adverse drug reactions Symptom management Biomarker
Details
Acute drug-induced liver injury associated with tolvaptan in a patient with cardiac amyloidosis: a case report

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1347-1352.
1966 times 344 times

YAO Tingyi ZHANG Weixia

Tolvaptan Drug-induced liver injury AL cardiac amyloidosis Heart failure
Details
MCUB as a novel biomarker for prognosis and its molecular characterization in cancer

Published on Frontiers in Pharmaceutical Sciences 2025,29(11):1853-1862.
2006 times 319 times

LYU Xiaodan LIU Pingyu

Mitochondrial calcium uniporter dominant negative subunit beta Pan-cancer analysis Prognostic biomarker Immune infiltration Drug sensitivity Protein-protein interaction The cancer genome atlas
Details
Analysis of adverse reaction signals of denosumab combined with vitamin D based on the FAERS database

Published on Frontiers in Pharmaceutical Sciences 2025,29(11):1898-1905.
2071 times 303 times

SHEN Yang CHEN Jihang

Denosumab Vitamin D FAERS database Adverse drug events Osteoporosis Signal mining Off-label use Benign giant cell tumor of bone Myalgia
Details
Application of valsartan in combination with amlodipine in adverse reactions in elderly patients with hypertension

Published on Frontiers in Pharmaceutical Sciences 2025,29(11):1906-1913.
2116 times 298 times

ZHOU Yan SU Fei ZHU Junjun LYU Xiongsheng

Valsartan Amlodipine Hypertension Elderly FAERS database Adverse drug event Rational drug use Signal mining
Details
The effect of JAK2 rs10119004 genetic polymorphism and C-reactive protein on voriconazole serum trough concentration in patients with invasive fungal disease

Published on Frontiers in Pharmaceutical Sciences 2025,29(11):1914-1920.
1747 times 260 times

CHEN Jing ZENG Ying LU Hong SHI Qunzhi YAN Pan MAO Yanmei

Voriconazole C-reactive protein Inflammation JAK2 gene polymorphism Therapeutic drug monitoring Invasive fungal infection Administration route Individualized administration Pulmonary infection
Details
Research progress and hotspots in Sophorae tonkinensis toxicity: a visual analysis based on CiteSpace and VOSviewer

Published on Frontiers in Pharmaceutical Sciences 2025,29(11):1921-1930.
2026 times 296 times

LI Jinsha PEI Jingnan LI Qian WEI Cailiu HOU Ling ZHANG Hongping DENG Jiagang

Sophorae tonkinensis Toxicity Bibliometrics Visual analysis CiteSpace VOSviewer Rational drug use Metabonomics
Details
Signal mining and analysis of drug-related thrombocytopenia based on FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2025,34(12):1382-1389.
1834 times 378 times

ZHOU Guowei ZHANG Hongyan JIAO Yanyan QUAN Xianghua

Thrombocytopenia Adverse drug events FAERS database Pharmacovigilance Signal mining
Details
Retrospective analysis of immune checkpoint inhibitor-induced colitis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(12):1390-1398.
1192 times 295 times

SONG Jialin WU Lei WANG Yiting

Immune checkpoint inhibitors Drug-induced colitis Immunotherapy toxicity Risk factors Retrospective analysis
Details